Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Feedback ( (GB:FDBK) ) just unveiled an announcement.
Feedback plc, the AIM-quoted clinical infrastructure specialist behind the Bleepa® collaboration platform, provides SaaS-based digital tools that connect healthcare systems, enable asynchronous clinical working and support the shift from analogue hospital-centric models to more efficient, community-based care. Its products target both public and private healthcare providers, including the NHS, aiming to boost productivity and care coordination while delivering more predictable, scalable revenues.
The company has appointed Chief Financial Officer Emma Oswick (Stuart) to its Board of Directors, formalising her role in governance from 16 February 2026 following her arrival in November 2025. Management highlighted her experience in subscription-led technology businesses, strategic change, financial optimisation and M&A as critical to steering Feedback through a pivotal growth phase, with CEO Tom Oakley stressing her contribution as Bleepa seeks to capitalise on rising demand for digital health solutions amid heightened government focus on healthcare digital transformation.
The most recent analyst rating on (GB:FDBK) stock is a Hold with a £10.50 price target. To see the full list of analyst forecasts on Feedback stock, see the GB:FDBK Stock Forecast page.
Spark’s Take on GB:FDBK Stock
According to Spark, TipRanks’ AI Analyst, GB:FDBK is a Neutral.
The score is held down primarily by deteriorating financial performance (sharp revenue decline, very large/worsening losses, and ongoing cash burn), partially offset by a debt-free balance sheet. Technicals add modest support due to an upward trend, but extremely overbought signals raise near-term risk. Valuation provides limited support given negative earnings and no dividend yield data.
To see Spark’s full report on GB:FDBK stock, click here.
More about Feedback
Feedback plc is a clinical infrastructure specialist focused on digital connectivity and asynchronous collaboration in health and social care. Through its award-winning Bleepa® software-as-a-service platform, the company connects healthcare systems to improve patient pathways, support the shift from hospital to community care, and help organisations such as the NHS enhance productivity using existing clinical workforces.
The company’s technology enables secure information sharing, flexible working and better-coordinated care across public and private healthcare markets in the U.K. and internationally. Its scalable SaaS model is designed to increase revenue visibility as the customer base grows, positioning Feedback as a strategic digital partner amid accelerating healthcare digital transformation.
Average Trading Volume: 88,890
Technical Sentiment Signal: Sell
Current Market Cap: £4.71M
For a thorough assessment of FDBK stock, go to TipRanks’ Stock Analysis page.